Bath & Body Works
BBWINYSEUSD
- — Source valuation snapshot. Not a live recalculation.
- — Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- — Diluted earnings per share from the latest filed annual.
- $21.65 Prior regular-session close from the quote source.
- $21.21–$21.86 Regular-session low and high so far today.
- 693.2K Regular-session shares traded · Nov 11, 11:27 AM ET.
- Nov 19 projected Projected for 2026-11-19 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $14.28–$24.94 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own BBWI if its scent-led personal care and home fragrance franchise stabilizes demand without sacrificing its historically strong merchandise margins.
BBWI price history
Loading recent earnings…
INVESTMENT THESIS
What must happen next
Bath & Body Works’ affordable self-care and gifting positioning remains relevant enough that personal care and home fragrance demand stabilizes rather than continuing to leak to mass, beauty, and online alternatives.HoldingMateriality: High
GAAP annual revenue was still $7.291 billion in FY2026, indicating the franchise remains large. If the customer habit holds, modest growth can support strong cash generation; if the habit weakens, the fixed retail model loses leverage quickly.
Watch: Younger shoppers migrate their fragrance and body-care spending to Sephora, Ulta, or social-media-native indie brands.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue was still $7.291 billion in FY2026, indicating the franchise remains large.
Open source ↗The brand’s proprietary fragrances and seasonal merchandising allow Bath & Body Works to use promotions as traffic drivers without permanently surrendering pricing power to discounting.StrengtheningMateriality: High
GAAP annual gross profit was $3.189 billion in FY2026. This determines whether sales stabilization is valuable or merely bought with lower merchandise profitability.
Watch: Customers become conditioned to buy only during deep candle, soap, or body-care promotions.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual gross profit was $3.189 billion in FY2026.
Open source ↗The store-led operating model can keep converting brand traffic into high operating profit only if wage, rent, marketing, and technology investments do not outgrow sales productivity.HoldingMateriality: Medium
GAAP annual operating income remained substantial at $1.126 billion in FY2026. Operating leverage is the difference between a cash compounder and a stagnant retailer with declining earnings power.
Watch: Store traffic weakens enough that occupancy and labor costs deleverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income remained substantial at $1.126 billion in FY2026.
Open source ↗Bath & Body Works’ working-capital and merchandise model remains cash generative enough to fund reinvestment and balance-sheet repair without relying on external capital.StrengtheningMateriality: Medium
GAAP annual operating cash flow was $1.102 billion in FY2026. Strong cash conversion gives owners downside protection and capital-allocation flexibility; a cash-flow break would make leverage much more dangerous.
Watch: Inventory misreads force markdowns and trap cash in unsold seasonal product.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was $1.102 billion in FY2026.
Open source ↗The leveraged balance sheet makes the equity sensitive to any durable break in brand demand or margins, so management must prioritize cash resilience over financial engineering.StrengtheningMateriality: Medium
FY2026 liabilities were $6.348 billion. High operating cash flow can support equity value, but leverage magnifies the damage if operating performance deteriorates.
Watch: Credit markets tighten or lenders demand more conservative terms for specialty retailers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2026 liabilities were $6.348 billion.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Bath & Body Works’ affordable self-care and gifting positioning remains relevant enough that personal care and home fragrance demand stabilizes rather than continuing to leak to mass, beauty, and online alternatives. If the customer habit holds, modest growth can support strong cash generation; if the habit weakens, the fixed retail model loses leverage quickly.
The brand’s proprietary fragrances and seasonal merchandising allow Bath & Body Works to use promotions as traffic drivers without permanently surrendering pricing power to discounting. This determines whether sales stabilization is valuable or merely bought with lower merchandise profitability.
The store-led operating model can keep converting brand traffic into high operating profit only if wage, rent, marketing, and technology investments do not outgrow sales productivity. Operating leverage is the difference between a cash compounder and a stagnant retailer with declining earnings power.
Bath & Body Works’ working-capital and merchandise model remains cash generative enough to fund reinvestment and balance-sheet repair without relying on external capital. Strong cash conversion gives owners downside protection and capital-allocation flexibility; a cash-flow break would make leverage much more dangerous.
The leveraged balance sheet makes the equity sensitive to any durable break in brand demand or margins, so management must prioritize cash resilience over financial engineering. High operating cash flow can support equity value, but leverage magnifies the damage if operating performance deteriorates.
All standing thesis claims
Original report summary
its scent-led personal care and home fragrance franchise stabilizes demand without sacrificing its historically strong merchandise margins.
BULL CASE / BEAR CASE
Bull case and bear case for Bath & Body Works
Where the evidence on Bath & Body Works stands: Holding on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.
Bull case: what the evidence supports
Bath & Body Works’ affordable self-care and gifting positioning remains relevant enough that personal care and home fragrance demand stabilizes rather than continuing to leak to mass, beauty, and online alternatives.
The brand’s proprietary fragrances and seasonal merchandising allow Bath & Body Works to use promotions as traffic drivers without permanently surrendering pricing power to discounting.
The store-led operating model can keep converting brand traffic into high operating profit only if wage, rent, marketing, and technology investments do not outgrow sales productivity.
Bath & Body Works’ working-capital and merchandise model remains cash generative enough to fund reinvestment and balance-sheet repair without relying on external capital.
The leveraged balance sheet makes the equity sensitive to any durable break in brand demand or margins, so management must prioritize cash resilience over financial engineering.
Bear case: what would count against it
Younger shoppers migrate their fragrance and body-care spending to Sephora, Ulta, or social-media-native indie brands.
Customers become conditioned to buy only during deep candle, soap, or body-care promotions.
Store traffic weakens enough that occupancy and labor costs deleverage.
Thesis-Break Engine
Thesis-break watch · Bath & Body Works
No break has crossed Bath & Body Works’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MIXEDDirector or principal officer change.
Bath & Body Works filed an SEC 8-K on 2026-09-23: Director or principal officer change. It is a dated development that tests the current thesis.
- MIXEDReported results of operations (earnings release).
Bath & Body Works filed an SEC 8-K on 2026-08-26: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MIXEDRegulation FD disclosure.
Bath & Body Works filed an SEC 8-K on 2026-07-20: Regulation FD disclosure. It is a dated development that tests the current thesis.
RISKS / FALSIFIERS
What could break the thesis
- Younger shoppers migrate their fragrance and body-care spending to Sephora, Ulta, or social-media-native indie brands.
- Customers become conditioned to buy only during deep candle, soap, or body-care promotions.
- Store traffic weakens enough that occupancy and labor costs deleverage.
- Inventory misreads force markdowns and trap cash in unsold seasonal product.
- Credit markets tighten or lenders demand more conservative terms for specialty retailers.
BBWI news
Loading headlines…
FINANCIAL STATEMENTS
BBWI income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
BBWI: quick answers
- When does Bath & Body Works (BBWI) report earnings next?
- Bath & Body Works's next results are projected for November 19, 2026, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on August 26, 2026. Earnings calendar
- What is BBWI's short interest?
- As of October 30, 2026, 15.4M BBWI shares were sold short, 7.65% of its shares outstanding, down 12.0% from the count before. At the stock's average daily volume that is 2.5 days to cover. FINRA publishes the count twice a month. BBWI short interest history
- Have members of Congress traded BBWI?
- 3 trades in BBWI have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed BBWI trade
- Which well-known investors own BBWI?
- 1 of the 37 well-known funds tracked here reported BBWI shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
BBWI in well-known investors’ portfolios
1 of 37 funds reported BBWI shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.01% | $2.4M | New | Q2 2026 |
